97 related articles for article (PubMed ID: 26091184)
21. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
22. The regulatory pattern of target gene expression by aberrant enhancer methylation in glioblastoma.
Zhao X; Ji J; Wang S; Wang R; Yu Q; Li D
BMC Bioinformatics; 2021 Sep; 22(1):420. PubMed ID: 34482818
[TBL] [Abstract][Full Text] [Related]
23. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
24. Integration of gene expression and methylation to unravel biological networks in glioblastoma patients.
Gadaleta F; Bessonov K; Van Steen K
Genet Epidemiol; 2017 Feb; 41(2):136-144. PubMed ID: 28019039
[TBL] [Abstract][Full Text] [Related]
25. Identifying multi-layer gene regulatory modules from multi-dimensional genomic data.
Li W; Zhang S; Liu CC; Zhou XJ
Bioinformatics; 2012 Oct; 28(19):2458-66. PubMed ID: 22863767
[TBL] [Abstract][Full Text] [Related]
26. miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
Dong L; Li Y; Han C; Wang X; She L; Zhang H
Int J Oncol; 2014 Aug; 45(2):746-56. PubMed ID: 24858071
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.
Alfardus H; McIntyre A; Smith S
Biomed Res Int; 2017; 2017():9157370. PubMed ID: 28804724
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme.
Li W; Li K; Zhao L; Zou H
Gene; 2014 Sep; 547(2):346-50. PubMed ID: 24967941
[TBL] [Abstract][Full Text] [Related]
29. Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
Bozdag S; Li A; Riddick G; Kotliarov Y; Baysan M; Iwamoto FM; Cam MC; Kotliarova S; Fine HA
PLoS One; 2013; 8(4):e62982. PubMed ID: 23658659
[TBL] [Abstract][Full Text] [Related]
30. Identifying glioblastoma gene networks based on hypergeometric test analysis.
Stathias V; Pastori C; Griffin TZ; Komotar R; Clarke J; Zhang M; Ayad NG
PLoS One; 2014; 9(12):e115842. PubMed ID: 25551752
[TBL] [Abstract][Full Text] [Related]
31. MiR-224 expression increases radiation sensitivity of glioblastoma cells.
Upraity S; Kazi S; Padul V; Shirsat NV
Biochem Biophys Res Commun; 2014 May; 448(2):225-30. PubMed ID: 24785373
[TBL] [Abstract][Full Text] [Related]
32. Gene regulation in glioblastoma: a combinatorial analysis of microRNAs and transcription factors.
Gong X; Sun J; Zhao Z
Int J Comput Biol Drug Des; 2011; 4(2):111-26. PubMed ID: 21712563
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic mechanisms in glioblastoma multiforme.
Nagarajan RP; Costello JF
Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways.
Liu J; Albrecht AM; Ni X; Yang J; Li M
Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007
[TBL] [Abstract][Full Text] [Related]
35. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
[TBL] [Abstract][Full Text] [Related]
36. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
Wang G; Wang JJ; Tang HM; To SS
Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
[TBL] [Abstract][Full Text] [Related]
37. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
[TBL] [Abstract][Full Text] [Related]
38. Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
Jones DC; Scanteianu A; DiStefano M; Bouhaddou M; Birtwistle MR
PLoS One; 2018; 13(1):e0190664. PubMed ID: 29342193
[TBL] [Abstract][Full Text] [Related]
39. Drug and disease signature integration identifies synergistic combinations in glioblastoma.
Stathias V; Jermakowicz AM; Maloof ME; Forlin M; Walters W; Suter RK; Durante MA; Williams SL; Harbour JW; Volmar CH; Lyons NJ; Wahlestedt C; Graham RM; Ivan ME; Komotar RJ; Sarkaria JN; Subramanian A; Golub TR; Schürer SC; Ayad NG
Nat Commun; 2018 Dec; 9(1):5315. PubMed ID: 30552330
[TBL] [Abstract][Full Text] [Related]
40. A Heterogeneous Network Based Method for Identifying GBM-Related Genes by Integrating Multi-Dimensional Data.
Chen Peng ; Ao Li
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(3):713-720. PubMed ID: 28113912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
